$50 million to support biotech companies.
In order to ensure the continuity of the financing chain for the life sciences sector, the government of Quebec announces the renewal of BioMed Propulsion. This will be allocated an envelope of $50 million to support biotechnology and medical technology companies which have already reached the early stages of their development and which offer growth potential. The objective: to promote the commercialization of the results of their research. Read:
https://www.quebec.ca/nouvelles/actualites/details/strategie-quebecoise-des-sciences-de-la-vie-2022-2025-une-enveloppe-dinvestissement-de-50-m-pour-renouveler-biomed-propulsion-50833
